Supreme Court Grapples with What Makes Processes Patentable in Prometheus v. Mayo – Genetic Engineering News

January 11, 2012 Posted By: Leave a comment
Specifically, Breyer read the amicus brief of Novartis, which argued that Metabolite’s correlation did not preempt a natural law, but was a patent-eligible application of natural law to facilitate a diagnosis and treatment of vitamin B deficiencies.
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>